Skip to main content
. 2022 May 7;26:128. doi: 10.1186/s13054-022-03977-3

Table 1.

Demographic and day 1 clinical characteristics of the four phenotypes

Characteristic1 Total PedSep-A PedSep-B PedSep-C PedSep-D
No. of patients, N (%) 404 (100) 136 (34) 102 (25) 110 (27) 56 (14)
Demographic
 Age years* mean (SD) 7 (6) 3 (4) 8 (6)a 10 (5)a,b 8 (6)a
 Male* N (%) 224 (55.4) 63 (46.3) 68 (66.7)a 59 (53.6) 34 (60.7)
 Female* N (%) 180 (44.6) 73 (53.7) 34 (33.3) 51 (46.4) 22 (39.3)
 Hispanic* N (%) 67 (16.6) 28 (20.6) 12 (11.8) 23 (20.9) 4 (7.1)
 Non-Hispanic* N (%) 323 (80.0) 100 (73.5) 86 (84.3) 86 (78.2) 51 (91.1)
 Previous healthy* N (%) 180 (44.6) 96 (70.6)b,c,d 28 (27.5) 37 (33.6) 19 (33.9)
 Surgery* N (%) 49 (12.1) 6 (4.4) 19 (18.6)a 12 (10.9) 12 (21.4)a
Organ dysfunction
 SIRS criteria, mean (SD)2 2.9 (0.8) 2.9 (0.8) 3.0 (0.8) 2.8 (0.8) 3 (0.8)
 OFI* mean (SD)3 1.8 (0.9) 1.4 (0.5) 2.1 (0.6)a,c 1.4 (0.6) 3.1 (1.0)a,b,c
Inflammation
 CRP mg/dL* mean (SD) 11.7 (10.4) 7.3 (7.3) 13.2 (11.5)a 15.2 (10.4)a 13.1 (11.2)a
 Low temperature °C* mean 36.6 (1.2) 36.7 (0.9)b 36.0 (1.6) 37.1 (0.9)a,b,d 36.3 (1.0)
 High temperature °C* mean 37.8 (1.3) 37.8 (1.1) 37.4 (1.3) 38.3 (1.2)a,b,d 37.8 (1.4)
 ALC/mm3* median (IQR) 1.2 (0.6–2.1) 1.9(1.3–3.2)b,c,d 1.1(0.6–1.9)c 0.6 (0.2–1.0) 1.1(0.6–2.1)c
 Ferritin ng/mL* median (IQR) 218 (98.0–625.3) 125(69.8–207.8) 223(116.5–544.2)a 405(176.2–1485.7)a,b 610 (221.1–2482.0)a,b
Pulmonary
 Pulmonary OFI* N (%) 270 (66.8) 108 (79.4)c 87 (85.3)c 37 (33.6) 38 (67.9)c
 Intubation* N (%) 211 (52.2) 72 (52.9)c 94 (92.2)a,c,d 15 (13.6) 30 (53.6)c
Cardiovascular or hemodynamic
 Heart rate bpm* mean (SD) 155.4 (31.3) 168.1 (30.8)b,c,d 146.5 (27.9) 150.4 (27.6) 150.6 (35.8)
 Systolic blood pressure*, mean (SD) mmHg 81.9 (19.3) 85.0 (15.7)b 74.8 (22.0) 86.3 (17.2)b 78.9 (21.9)
 Cardiovascular OFI* N (%) 284 (70.3) 63 (46.3) 92 (90.2)a 85 (77.3)a 44 (78.6)a
Renal
 Creatinine mg/dL* median (IQR) 0.5 (0.3–0.8) 0.3 (0.2–0.4) 0.6 (0.4–1.0)a 0.6 (0.4–0.7)a 1.4 (0.6–2.6)a,b,c
 Renal OFI* N (%) 30 (7.4) 0 (0.0) 0 (0.0) 0 (0.0) 30 (53.6)a,b,c
Hepatic
 Hepatic OFI* N (%) 40 (9.9) 3 (2.2) 9 (8.8) 11 (10.0)a 17 (30.4)a,b,c
Hematologic
 Hemoglobin g/dL* mean (SD) 9.8 (2.0) 10.1 (1.8)b,d 9.4 (2.1) 10.2 (2.1)b,d 9.1 (1.8)
 Platelets K/mm3* mean (SD) 171.1 (123.2) 260.1 (122.0)b,c,d 154.3 (95.1)c,d 118.8 (83.5)d 88.2 (108.0)
 Hematologic OFI* N (%) 39 (9.7) 0 (0.0) 0 (0.0) 8 (7.3)a,b 31 (85.7)a,b,c
Neurologic
 Glasgow Coma Scale Score* mean (SD)4,5 8.7 (5.3) 8.5 (5.2)b 4.7 (3.4) 13.2 (3.1)a,b,d 7.9 (5.5)b
 CNS OFI N (%) 54 (13.4) 12 (8.8) 24 (23.5)a,c 6 (5.5) 12 (21.4)c

IQR interquartile range, SIRS systemic inflammatory response syndrome, OFI organ failure index, ALC absolute lymphocyte count, CNS central nervous system

SI conversion factors: to convert alanine transaminase and aspartate aminotransferase to μkat/L, multiply by 0.0167; bilirubin to μmol/L, multiply by 17.104; C-reactive protein to nmol/L, multiply by 9.524; creatinine to μmol/L, multiply by 88.4

*Comparisons across all 4 computable phenotypes were performed using the Kruskal–Wallis test, the χ2 test, or the Fisher’s exact test (Additional file 1: Table S3, p < 0.05 for all comparisons after adjustment)

1The variables in this table were log transformed for modeling (Additional file 1: Table S3). Comparisons across all 4 phenotypes were performed using the Kruskal–Wallis test, the χ2 test, or the Fisher’s exact test (Additional file 1: Table S3. p < 0.05 for all comparisons after adjustment)

2Indicates SIRS criteria ranging from 0 to 4 including abnormal heart rate, respiratory rate, temperature, and white blood cell count

3OFI is an integer score reflecting the number of organ failures. Scores are either 0 or 1 for cardiovascular, hepatic, hematologic, respiratory, neurological, and renal, and summed for total range of 0 to 6. Cardiovascular, need for cardiovascular agent infusion support; Pulmonary, need for mechanical ventilation support with the ratio of the arterial partial pressure of oxygen and the fraction of inspired oxygen (PaO2/FiO2) < 300 without this support; Hepatic, total bilirubin > 1.0 mg/dL and alanine aminotransferase (ALT) > 100 units/L; Renal, serum creatinine > 1.0 mg/dL and oliguria (urine output < 0.5 mL/kg/h); Hematologic, thrombocytopenia < 100,000/mm3 and prothrombin time INR > 1.5 × normal; Central Nervous System, Glasgow Coma Scale (GCS) Score < 12 in the absence of sedatives

4Corresponds to minimum or maximum value (as appropriate) within 6 h of hospital presentation

5GCS ranges from 3 to 15

aThe outcome characteristic of this computable phenotype is significantly higher than PedSep-A (p value < 0.05)

bThe outcome characteristic of this computable phenotype is significantly higher than PedSep-B (p value < 0.05)

cThe outcome characteristic of this computable phenotype is significantly higher than PedSep-C (p value < 0.05)

dThe outcome characteristic of this computable phenotype is significantly higher than PedSep-D (p value < 0.05)